Skip to content

Analysis of the impacts of traditional Korean medicine treatment on elderly patients with cerebrovascular disease who are in a state of polypharmacy

Analysis of the impacts of traditional Korean medicine treatment on elderly patients with cerebrovascular disease who are in a state of polypharmacy: a retrospective chart review study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006722
Enrollment
1300
Registered
2021-11-09
Start date
2021-10-29
Completion date
Unknown
Last updated
2021-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyunghee University-industry Cooperation Foundation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were hospitalized and treated for cerebrovascular disease (I60, I61, I63) at Kyung Hee University Korean Medicine Hospital from January 01, 2015 to December 31, 2019 ( 65 years of age or older). It must satisfy the criteria of A or B below. A: In case of hospitalization after 21 days of onset of cerebrovascular disease B: Case hospitalized for more than 21 days immediately after onset of cerebrovascular disease

Exclusion criteria

Exclusion criteria: Patients with degenerative brain diseases (eg, Parkinson's disease, Alzheimer's disease, etc.), brain tumors, and other brain diseases such as traumatic brain injury.

Design outcomes

Primary

MeasureTime frame
Changes in the frequency of polypharmacy, potentially inappropriate medications and underuse before and after the use of oriental medicine treatment

Secondary

MeasureTime frame
Correlation between “improving the frequency of polypharmacy” and “improving the frequency of potentially inappropriate medications or underuse” before and after the combination of Korean medicine treatment;Comparison of improvement in National Institute of Health Stroke Scale (NIHSS) according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Comparison of improvement in modified Barthel Index (mBI) according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Comparison of improvement in cognitive impairment according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Comparison of frequency of liver function abnormality according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Comparison of frequency of renal function abnormality according to “improvement/non-improvement of polypharmacy, improvement/non-improvement of potentially inadequate medication, improvement/non-improvement of underuse”;Analysis of factors affecting “improvement of polypharmacy, potentially inadequate prescription, and underuse”

Countries

Korea, Republic of

Contacts

Public ContactSeungwon Kwon

Kyung Hee University Oriental Medical Center

kmdkwon@gmail.com+82-2-958-9190

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026